Orchard Therapeutics
IPOHomepage
- Headquarters
- London
- Business Model
- B2B
- Website
- orchard-tx.com
- Total Funding
- $293.0M
- Last Round
- $150.0M Series CAug 2018
- Rounds
- 3
About
Gene therapy company focused on treatments for severe genetic diseases.
Summary
Orchard Therapeutics is a Biotech company based in London, United Kingdom. It has raised $293.0M in total across 3 rounds, most recently a $150.0M Series C round in Aug 2018. Investors include F-Prime Capital and RA Capital Management.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2018
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Food technology company creating plant-based meat and dairy products that replicate the taste and...